NOW APPROVED
The first and only
FDA-approved treatment of
its kind for erosive esophagitis
(erosive acid reflux)

---

Can help heal and maintain healing of Erosive Acid Reflux
for most adults

VOQUEZNA (vonoprazan) was evaluated in a clinical study of adults with endoscopically confirmed Erosive Acid Reflux. One group took VOQUEZNA 20 mg once daily for 2 to 8 weeks during the healing phase. 93% of adults taking VOQUEZNA for Erosive Acid Reflux experienced healing by 2 months (compared to 85% taking another treatment*).

Some adults who were healed by VOQUEZNA or another treatment during the healing phase then took VOQUEZNA 10 mg once daily for up to 6 months during the maintenance phase. 79% of those stayed healed for 6 months on VOQUEZNA maintenance treatment (compared to 72% taking another treatment*).

Effective heartburn relief for most adults with
Erosive Acid Reflux

In a clinical study, adults with Erosive Acid Reflux taking VOQUEZNA were asked to keep track of the days they experienced heartburn and the severity of heartburn symptoms. Diaries were checked after 2 months to identify how many days were reported to be heartburn free. Diaries were checked after 6 months for adults who were healed in the healing phase of the trial. During the 2-month healing phase, 67% of days spent on VOQUEZNA were heartburn free for 24 hours (compared to 64% of days on another treatment*). Over the 6-month maintenance phase, 81% of days spent on VOQUEZNA were heartburn free for 24 hours (compared to 79% of days on another treatment*).

*Iansoprazole